Dr. James J. Nyamataga's research interests include hematologic malignancies, cancer genomics, translational oncology, and precision medicine in resource-limited settings. His work focuses on understanding the molecular and clinical characteristics of multiple myeloma and other blood cancers in African populations to improve diagnosis, prognostication, and treatment outcomes. He has experience in clinical research, biobanking, epidemiologic studies, next-generation sequencing, bioinformatics, and health outcomes research. Through multidisciplinary collaborations with national and international partners such as the Multiple Myeloma Research Foundation and the International Myeloma Society, Dr. Nyamataga is advancing studies on tumor biology, genomic profiling, and cancer disparities while contributing to the development of sustainable research infrastructure and capacity in Tanzania. His broader academic mission is to bridge laboratory discoveries with clinical practice and strengthen locally generated evidence to inform cancer care, policy, and precision oncology initiatives across sub-Saharan Africa.